[Federal Register Volume 80, Number 60 (Monday, March 30, 2015)]
[Notices]
[Pages 16675-16677]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-07200]


-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OPP-2015-0057; FRL-9922-79]


Registration Review; Pesticide Dockets Opened for Review and 
Comment

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: With this document, EPA is opening the public comment period 
for several registration reviews. Registration review is EPA's periodic 
review of pesticide registrations to ensure that each pesticide 
continues to satisfy the statutory standard for registration, that is, 
the pesticide can perform its intended function without unreasonable 
adverse effects on human health or the environment. Registration review 
dockets contain information that will assist the public in 
understanding the types of information and issues that the Agency may 
consider during the course of registration reviews. Through this 
program, EPA is ensuring that each pesticide's registration is based on 
current scientific and other knowledge, including its effects on human 
health and the environment. This document also announces the Agency's 
intent to close the registration review case for tebufenpyrad, 
imazamethabenz, and 2-((hydroxymethyl)-amino)ethanol (also known as 
HMAE). These pesticides do not currently have any actively registered 
pesticide products and, therefore, the Agency is closing the 
registration review cases for tebufenpyrad, imazamethabenz, and HMAE.
    For phenmedipham, EPA is seeking comment on the preliminary work 
plan, the ecological problem formulation, and the human health draft 
risk assessment.

DATES: Comments must be received on or before May 29, 2015.

ADDRESSES: Submit your comments identified by the docket identification 
(ID) number for the specific pesticide of interest provided in the 
table in Unit III.A., by one of the following methods:
    <bullet> Federal eRulemaking Portal: http://www.regulations.gov. 
Follow the online instructions for submitting comments. Do not submit 
electronically any information you consider to be Confidential Business 
Information (CBI) or other information whose disclosure is restricted 
by statute.
    <bullet> Mail: OPP Docket, Environmental Protection Agency Docket 
Center (EPA/DC), (28221T), 1200 Pennsylvania Ave. NW., Washington, DC 
20460-0001.
    <bullet> Hand Delivery: To make special arrangements for hand 
delivery or delivery of boxed information, please follow the 
instructions at http://www.epa.gov/dockets/contacts.html.
    Additional instructions on commenting or visiting the docket, along 
with more information about dockets generally, is available at http://www.epa.gov/dockets.

FOR FURTHER INFORMATION CONTACT:
For pesticide specific information, contact: The Chemical Review 
Manager for the pesticide of interest identified in the table in Unit 
III.A.
For general information contact: Richard Dumas, Pesticide Re-Evaluation 
Division (7508P), Office of Pesticide Programs, Environmental 
Protection Agency, 1200 Pennsylvania Ave. NW., Washington, DC 20460-
0001; telephone number: (703) 308-8015; fax number: (703) 308-8005; 
email address: <a href="/cdn-cgi/l/email-protection#eb8f9e868a98c5998288838a998fab8e9b8ac58c849d"><span class="__cf_email__" data-cfemail="d0b4a5bdb1a3fea2b9b3b8b1a2b490b5a0b1feb7bfa6">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION:

I. General Information

A. Does this action apply to me?

    This action is directed to the public in general, and may be of 
interest to a wide range of stakeholders including environmental, human 
health, farmworker, and agricultural advocates; the chemical industry; 
pesticide users; and members of the public interested in the sale, 
distribution, or use of pesticides. Since others also may be 
interested, the Agency has not attempted to describe all the specific 
entities that may be affected by this action.

B. What should I consider as I prepare my comments for EPA?

    1. Submitting CBI. Do not submit this information to EPA through 
regulations.gov or email. Clearly mark the part or all of the 
information that you claim to be CBI. For CBI information in a disk or 
CD-ROM that you mail to EPA, mark the outside of the disk or CD-ROM as 
CBI and then identify electronically within the disk or CD-ROM the 
specific information that is claimed as CBI. In addition to one 
complete version of the comment that includes information claimed as 
CBI, a

[[Page 16676]]

copy of the comment that does not contain the information claimed as 
CBI must be submitted for inclusion in the public docket. Information 
so marked will not be disclosed except in accordance with procedures 
set forth in 40 CFR part 2.
    2. Tips for preparing your comments. When preparing and submitting 
your comments, see the commenting tips at http://www.epa.gov/dockets/comments.html.
    3. Environmental justice. EPA seeks to achieve environmental 
justice, the fair treatment and meaningful involvement of any group, 
including minority and/or low income populations, in the development, 
implementation, and enforcement of environmental laws, regulations, and 
policies. To help address potential environmental justice issues, the 
Agency seeks information on any groups or segments of the population 
who, as a result of their location, cultural practices, or other 
factors, may have atypical or disproportionately high and adverse human 
health impacts or environmental effects from exposure to the pesticides 
discussed in this document, compared to the general population.

II. Authority

    EPA is initiating its reviews of the pesticides identified in this 
document pursuant to section 3(g) of the Federal Insecticide, 
Fungicide, and Rodenticide Act (FIFRA) (7 U.S.C. 136a(g)) and the 
Procedural Regulations for Registration Review at 40 CFR part 155, 
subpart C. Section 3(g) of FIFRA provides, among other things, that the 
registrations of pesticides are to be reviewed every 15 years. Under 
FIFRA, a pesticide product may be registered or remain registered only 
if it meets the statutory standard for registration given in FIFRA 
section 3(c)(5) (7 U.S.C. 136a(c)(5)). When used in accordance with 
widespread and commonly recognized practice, the pesticide product must 
perform its intended function without unreasonable adverse effects on 
the environment; that is, without any unreasonable risk to man or the 
environment, or a human dietary risk from residues that result from the 
use of a pesticide in or on food.

III. Registration Reviews

A. What action is the Agency taking?

    As directed by FIFRA section 3(g), EPA is reviewing the pesticide 
registrations identified in the table in this unit to assure that they 
continue to satisfy the FIFRA standard for registration--that is, they 
can still be used without unreasonable adverse effects on human health 
or the environment. A pesticide's registration review begins when the 
Agency establishes a docket for the pesticide's registration review 
case and opens the docket for public review and comment. At present, 
EPA is opening registration review dockets for the cases identified in 
the following table.

                                  Table 1--Registration Review Dockets Opening
----------------------------------------------------------------------------------------------------------------
  Registration review case name and                                                  Chemical review manager,
                 No.                           Pesticide docket ID No.           telephone number, email address
----------------------------------------------------------------------------------------------------------------
Bioban P-1487 (Case 3028)...........  EPA-HQ-OPP-2014-0802.....................  SanYvette Williams, 703-305-
                                                                                  7702,
                                                                                  <a href="/cdn-cgi/l/email-protection#4e39272222272f233d603d2f2037382b3a3a2b0e2b3e2f60292138"><span class="__cf_email__" data-cfemail="74031d18181d1519075a07151a0d0211000011341104155a131b02">[email protected]</span></a>.
Bis(bromoacetoxy)-2-butene (BBAB)     EPA-HQ-OPP-2014-0799.....................  Tina Pham, 703-308-0125,
 (Case 3030).                                                                     <a href="/cdn-cgi/l/email-protection#7d0d151c105309151c123d180d1c531a120b"><span class="__cf_email__" data-cfemail="2a5a424b47045e424b456a4f5a4b044d455c">[email protected]</span></a>.
Carboxin and Oxycarboxin (Case 0012)  EPA-HQ-OPP-2015-0144.....................  Dana L. Friedman, 703-347-8827,
                                                                                  <a href="/cdn-cgi/l/email-protection#8debffe4e8e9e0ece3a3e9ece3eccde8fdeca3eae2fb"><span class="__cf_email__" data-cfemail="2244504b47464f434c0c46434c43624752430c454d54">[email protected]</span></a>.
Copper HDO (Case 5106)..............  EPA-HQ-OPP-2014-0800.....................  Donna Kamarei, 703-347-0443,
                                                                                  <a href="/cdn-cgi/l/email-protection#402b212d213225296e242f2e2e21002530216e272f36"><span class="__cf_email__" data-cfemail="107b717d716275793e747f7e7e71507560713e777f66">[email protected]</span></a>.
Chondrostereum Purpureum (Case 6091)  EPA-HQ-OPP-2015-0051.....................  Kathleen Martin, 703-308-2857,
                                                                                  <a href="/cdn-cgi/l/email-protection#137872677b7f76767d3d7e7261677a7d537663723d747c65"><span class="__cf_email__" data-cfemail="f29993869a9e97979cdc9f9380869b9cb2978293dc959d84">[email protected]</span></a>.
Creosote (Case 0139)................  EPA-HQ-OPP-2014-0823.....................  Sandra O'Neill, 703-347-0141,
                                                                                  <a href="/cdn-cgi/l/email-protection#127d7c777b7e7e3c61737c766073527762733c757d64"><span class="__cf_email__" data-cfemail="2c434249454040025f4d42485e4d6c495c4d024b435a">[email protected]</span></a>.
Cyazofamid (Case 7656)..............  EPA-HQ-OPP-2015-0128.....................  Jose Gayoso, 703-347-8652,
                                                                                  <a href="/cdn-cgi/l/email-protection#96f1f7eff9e5f9b8fcf9e5f3d6f3e6f7b8f1f9e0"><span class="__cf_email__" data-cfemail="1572746c7a667a3b7f7a6670557065743b727a63">[email protected]</span></a>.
Famoxadone (Case 7038)..............  EPA-HQ-OPP-2015-0094.....................  Christina Scheltema, 703-308-
                                                                                  2201,
                                                                                  <a href="/cdn-cgi/l/email-protection#f0839398959c84959d91de939882998384999e91b0958091de979f86"><span class="__cf_email__" data-cfemail="0576666d6069716068642b666d776c76716c6b64456075642b626a73">[email protected]</span></a>.
Lufenuron (Case 7627)...............  EPA-HQ-OPP-2015-0098.....................  Bonnie Adler, 703-308-8523,
                                                                                  <a href="/cdn-cgi/l/email-protection#18797c747d6a367a777676717d587d6879367f776e"><span class="__cf_email__" data-cfemail="81e0e5ede4f3afe3eeefefe8e4c1e4f1e0afe6eef7">[email protected]</span></a>.
Myclobutanil (Case 7006)............  EPA-HQ-OPP-2015-0053.....................  Benjamin Askin, 703-347-0503,
                                                                                  <a href="/cdn-cgi/l/email-protection#9effedf5f7f0b0fcfbf0f4fff3f7f0defbeeffb0f9f1e8"><span class="__cf_email__" data-cfemail="e584968e8c8bcb87808b8f84888c8ba5809584cb828a93">[email protected]</span></a>.
Novaluron (Case 7615)...............  EPA-HQ-OPP-2015-0171.....................  Margaret Hathaway, 703-305-
                                                                                  5076,
                                                                                  <a href="/cdn-cgi/l/email-protection#3850594c50594f59411655594a5f594a5d4c785d4859165f574e"><span class="__cf_email__" data-cfemail="3e565f4a565f495f4710535f4c595f4c5b4a7e5b4e5f10595148">[email protected]</span></a>.
Phenmedipham (Case 0277)............  EPA-HQ-OPP-2014-0546.....................  Miguel Zavala, 703-347-0504,
                                                                                  <a href="/cdn-cgi/l/email-protection#e993889f888588c784808e9c8c85a98c9988c78e869f"><span class="__cf_email__" data-cfemail="1c667d6a7d707d3271757b6979705c796c7d327b736a">[email protected]</span></a>.
Sethoxydim (Case 2600)..............  EPA-HQ-OPP-2015-0088.....................  James Parker, 703-306-0469,
                                                                                  <a href="/cdn-cgi/l/email-protection#750514071e10075b1f14181006351005145b121a03"><span class="__cf_email__" data-cfemail="473726352c2235692d262a22340722372669202831">[email protected]</span></a>.
Spirodiclofen (Case 7443)...........  EPA-HQ-OPP-2014-0262.....................  Julia Stokes, 703-347-8966,
                                                                                  <a href="/cdn-cgi/l/email-protection#394a4d56525c4a17534c555058795c4958175e564f"><span class="__cf_email__" data-cfemail="7003041f1b15035e1a051c1911301500115e171f06">[email protected]</span></a>.
Spiromesifen (Case 7442)............  EPA-HQ-OPP-2014-0263.....................  Julia Stokes, 703-347-8966,
                                                                                  <a href="/cdn-cgi/l/email-protection#bbc8cfd4d0dec895d1ced7d2dafbdecbda95dcd4cd"><span class="__cf_email__" data-cfemail="2457504b4f41570a4e51484d45644154450a434b52">[email protected]</span></a>.
----------------------------------------------------------------------------------------------------------------

    For phenmedipham (Case 0277) EPA is seeking comment on the 
preliminary Work Plan, the ecological problem formulation, and the 
human health draft risk. For Forchlorfenuron (Case 7057), EPA is 
seeking comment on the Combined Work Plan, Summary Document, and 
Proposed Interim Registration Review Decision, which includes the human 
health and ecological risk assessments. The Agency also is announcing 
the intent to close the registration review cases for tebufenpyrad, 
imazamethabenz, and 2-(hydroxymethyl)- amino)ethanol also known as 
HMAE. These pesticides do not currently have any actively registered 
pesticide products and, therefore, the Agency is closing the 
registration review cases for tebufenpyrad, imazamethabenz, and HMAE. 
The tebufenpyrad registration review case is being closed because the 
last products were canceled in the Federal Register notice dated 
September 24, 2014 (79 FR 57087) (FRL-9916-69). The ``Notice of 
Registration Review Case Closure'' for tebufenpyrad is available in 
docket EPA-HQ-OPP-2014-0218 at http://www.regulations.gov. For 
phenmedipham (Case 0277), EPA is seeking comment on the preliminary 
work plan, the ecological problem formulation, and the human health 
draft risk assessment. The imazamethabenz registration review case is 
being closed because the last products were canceled in the Federal 
Register. The ``Notice of Registration Review Case Closure'' for 
imazamethabenz is available in docket EPA-HQ-OPP-2014-0394 at http://www.regulations.gov.

B. Docket Content

    1. Review dockets. The registration review dockets contain 
information that the Agency may consider in the course of the 
registration review. The Agency may include information from its files 
including, but not limited to, the following information:
    <bullet> An overview of the registration review case status.
    <bullet> A list of current product registrations and registrants.
    <bullet> Federal Register notices regarding any pending 
registration actions.

[[Page 16677]]

    <bullet> Federal Register notices regarding current or pending 
tolerances.
    <bullet> Risk assessments.
    <bullet> Bibliographies concerning current registrations.
    <bullet> Summaries of incident data.
    <bullet> Any other pertinent data or information.
    Each docket contains a document summarizing what the Agency 
currently knows about the pesticide case and a preliminary work plan 
for anticipated data and assessment needs. Additional documents provide 
more detailed information. During this public comment period, the 
Agency is asking that interested persons identify any additional 
information they believe the Agency should consider during the 
registration reviews of these pesticides. The Agency identifies in each 
docket the areas where public comment is specifically requested, though 
comment in any area is welcome.
    2. Other related information. More information on these cases, 
including the active ingredients for each case, may be located in the 
registration review schedule on the Agency's Web site at http://www2.epa.gov/pesticide-reevaluation. Information on the Agency's 
registration review program and its implementing regulation may be seen 
at http://www2.epa.gov/pesticide-reevaluation/registration-review-schedules.
    3. Information submission requirements. Anyone may submit data or 
information in response to this document. To be considered during a 
pesticide's registration review, the submitted data or information must 
meet the following requirements:
    <bullet> To ensure that EPA will consider data or information 
submitted, interested persons must submit the data or information 
during the comment period. The Agency may, at its discretion, consider 
data or information submitted at a later date.
    <bullet> The data or information submitted must be presented in a 
legible and useable form. For example, an English translation must 
accompany any material that is not in English and a written transcript 
must accompany any information submitted as an audiographic or 
videographic record. Written material may be submitted in paper or 
electronic form.
    <bullet> Submitters must clearly identify the source of any 
submitted data or information.
    <bullet> Submitters may request the Agency to reconsider data or 
information that the Agency rejected in a previous review. However, 
submitters must explain why they believe the Agency should reconsider 
the data or information in the pesticide's registration review.
    As provided in 40 CFR 155.58, the registration review docket for 
each pesticide case will remain publicly accessible through the 
duration of the registration review process; that is, until all actions 
required in the final decision on the registration review case have 
been completed.

    Authority:  7 U.S.C. 136 et seq.

    Dated: March 18, 2015.
Richard P. Keigwin, Jr.,
Director, Pesticide Re-Evaluation Division, Office of Pesticide 
Programs.
[FR Doc. 2015-07200 Filed 3-27-15; 8:45 am]
 BILLING CODE 6560-50-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>